Donaco International Ltd.

DNA Details

Full year earnings guidance affirmed: Donaco International Ltd (ASX: DNA) has announced the performance of its operating venues, the Star Vegas and the Aristo International Hotel, as in line with earlier earnings guidance. Further, the company is completing the transition to full management control of Star Vegas, as the management contract with the former Thai vendor ended on 30 June 2017. Moreover, expansion to international customers proceeding well, with approximately 100 gaming tables expected to be added in the next few months, filling virtually all the available capacity at Star Vegas. Based on unaudited management accounts, the Star Vegas business has recorded EBITDA of US$61 million, while the Aristo has also performed strongly during FY17, benefiting from strategic initiatives implemented to enhance mass market visitation at the venue, and cost control measures. Unaudited EBITDA for FY17 grew by 38% yoy to RMB73.2million (US$10.8 million). Given the ongoing progress, we maintain a “Buy” recommendation on the stock at the current price of $0.53


DNA Daily chart; (Source: Thomson Reuters)

Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.